Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle View 
July 27, 2017Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update
July 20, 2017Pernix Commences Refinancing Transactions to Fortify Balance Sheet
July 20, 2017Pernix Therapeutics Pre-Announces Certain Preliminary Second Quarter 2017 Financial Results
June 28, 2017Pernix Therapeutics Added to Russell Microcap® Index
May 15, 2017Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update
May 8, 2017Pernix Therapeutics to Report First Quarter 2017 Financial Results on Monday, May 15
May 1, 2017Pernix Therapeutics Provides Update on Availability of Zohydro® ER with BeadTek™ 20mg Strength
March 28, 2017Pernix Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results
March 15, 2017Pernix Therapeutics to Report Fourth Quarter and Year-End 2016 Financial Results on Tuesday, March 28
February 23, 2017Pernix Therapeutics Prevails in Zohydro® ER ANDA Litigation
February 3, 2017Pernix Therapeutics Provides Update on Arbitration
January 6, 2017Pernix Therapeutics Appoints Ken Piña as General Counsel and Chief Compliance Officer
November 22, 2016Pernix Therapeutics Appoints New Board Member
November 10, 2016Pernix Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update
November 7, 2016Pernix Therapeutics Appoints Two Board Members
October 31, 2016Pernix Therapeutics to Report Third Quarter 2016 Financial Results on November 10, 2016
October 13, 2016Pernix Therapeutics Announces Reverse Stock Split and Corporate Governance Enhancements
September 28, 2016Pernix Therapeutics Announces Distribution of TREXIMET® 10/60 mg (sumatriptan 10mg and naproxen sodium 60 mg) Dose For Use in Pediatric Patients
September 16, 2016Marsha Stanton, Ph.D., RN, Pernix Therapeutics Executive Director of Medical and Government Affairs, Awarded Prestigious Pain Management Advocacy Award from the American Society for Pain Management Nursing®
September 14, 2016Pernix Therapeutics Announces the Issuance of Two New Orange Book Listed Patents for Zohydro® ER with BeadTek™
September 9, 2016Pernix Therapeutics Announces Significant Presence at PAINWeek 2016